Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.

Dottorini L, Viti M, Arru M, Senzani F, Petrelli F.

Open source

DOI
10.1245/s10434-026-20318-8
Published
2026-10-01
Container
Ann Surg Oncol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1245/s10434-026-20318-8,
  title = {Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.},
  author = {Dottorini L and  Viti M and  Arru M and  Senzani F and  Petrelli F.},
  year = {2026},
  journal = {Ann Surg Oncol},
  doi = {10.1245/s10434-026-20318-8},
  url = {https://doi.org/10.1245/s10434-026-20318-8}
}

RIS

TY  - JOUR
TI  - Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.
AU  - Dottorini L
AU  -  Viti M
AU  -  Arru M
AU  -  Senzani F
AU  -  Petrelli F.
PY  - 2026
JO  - Ann Surg Oncol
DO  - 10.1245/s10434-026-20318-8
UR  - https://doi.org/10.1245/s10434-026-20318-8
ER  - 

APA

L, D., M, V., M, A., F, S., & F., P. (2026). Correction: Neoadjuvant Chemotherapy in Resectable Colon Cancer: Evidence, Controversies, and an Implementation Roadmap for 2026.. Ann Surg Oncol. https://doi.org/10.1245/s10434-026-20318-8

Source records